National Cancer Institute

Rockville,  MD 
United States
http://www.cancer.gov
  • Booth: 7125

The NIH National Cancer Institute (NCI) leads, conducts, and supports cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives. As the leader of the cancer research enterprise, collectively known as the National Cancer Program, and the largest funder of cancer research in the world, NCI manages a broad range of research, training, and information dissemination activities that reach across the entire country, meeting the needs of all demographics—rich and poor, urban and rural, and all racial/ethnic populations.


 Show Specials


 Press Releases

  • The Breast Cancer Risk Assessment Tool

    The Breast Cancer Risk Assessment Tool allows health professionals to estimate a woman's risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk).

    The tool uses a woman’s personal medical and reproductive history and the history of breast cancer among her first-degree relatives (mother, sisters, daughters) to estimate absolute breast cancer risk—her chance or probability of developing invasive breast cancer in a defined age interval.

    https://bcrisktool.cancer.gov/ 

  • Childhood Cancer Data Initiative (CCDI)

    The Childhood Cancer Data Initiative (CCDI) focuses on the critical need to collect, analyze, and share data to address the burden of cancer in childrenadolescents, and young adults (AYAs). The initiative supports maximizing the use and benefit of data from childhood and AYA cancer research for patients and survivors and aims to make it easier for researchers to learn from each of the approximately 16,000 children and adolescents diagnosed with cancer in the United States each year.

    Tissue samples from patients with cancer in this age group are critically limited and a valuable resource. Data generated from these specimens are often fragmented in different databases and not broadly available to researchers and oncology teams. Optimizing the use of childhood and AYA cancer biospecimens and the resulting data will have a profound impact on our ability to prevent, diagnose, and treat this patient population, and can serve as a model for improving the use of data across cancer types and other disease continuums.

    The CCDI is a federal investment of $50 million proposed to be extended in equal amounts per year for the next 10 years. The first year of the initiative was funded in December 2019. These funds will allow NCI to enhance data sharing, collection, analysis, and access for ongoing and planned childhood and AYA cancer and survivorship research throughout the Institute.

    https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative 

  • The Cancer Information Service (CIS)

    Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions whether you are a patient, family member or friend, health care provider, or researcher. Our service is available in English and Spanish.

    We provide accurate, up-to-date, and reliable information that is easy to understand and free of charge. 

    CIS can also help you quit smoking. The Smoking Quitline number is 1-877-44U-QUIT (1-877-448-7848). The service is available in English and Spanish, Monday through Friday, 9 a.m. to 9 p.m. ET.

    Important: NCI provides cancer-related information for your general knowledge and is not a substitute for a doctor's advice.

    https://www.cancer.gov/contact

  • Resources for Researchers

    Resources for Researchers is a directory of NCI-supported tools and services for cancer researchers. Most resources are free of cost and available to anyone.
    https://www.cancer.gov/research/resources
  • Disparities - Cancer Currents Blog

    News and commentaries about cancer-related racial/ethnic and socioeconomic disparities. Includes stories on factors that influence disparities and efforts to address them.
    https://www.cancer.gov/news-events/cancer-currents-blog?topic=disparities

 Products

  • Commemorating 50 Years of the National Cancer Act
    There have been few events that have had as remarkable and long-lasting an impact on how cancer is studied, treated, and even contemplated as the National Cancer Act of 1971.

    That single piece of legislation set in motion a chain of events that created a research enterprise of unimaginable depth and complexity. The National Cancer Act of 1971 established NCI’s Cancer Centers Program and expanded the National Clinical Trials Network. It also cemented our nation’s commitment to basic research, without which many breakthroughs could not be made.

    At NCI, as we enter the 50th anniversary year of this landmark legislation, we’re taking the opportunity to commemorate those who have paved the path of progress. Throughout 2021, we’ll be sharing some of these stories of progress.

    We hope to provide a clear picture of where, as a community, we’ve been. Of course, we can’t underestimate the challenges that remain. But, hopefully, this look back over the past 50 years will help us all appreciate even more the progress that’s been and the promise that the future holds.
    ...